Sledenje bolnikov z rakom debelega črevesa in danke po radikalnem zdravljenju

Izpis gradiva
A+ | A- | | SLO | ENG

Naslov:	Sledenje bolnikov z rakom debelega črevesa in danke po radikalnem zdravljenju
Avtorji:	ID Oblak, Irena (Avtor)
Datoteke:	PDF - Predstavitvena datoteka, prenos (311,87 KB) MD5: 857CBB0A41BC0C1D449951CC8BE0DEC4 PID: 20.500.12556/dirros/cf8ffc74-a39a-4c8a-9325-4670a769c97a
Jezik:	Slovenski jezik
Tipologija:	1.08 - Objavljeni znanstveni prispevek na konferenci
Organizacija:	OI - Onkološki inštitut Ljubljana
Ključne besede:	bolniki, rak debelega črevesa, rak danke, rak prebavil
Status publikacije:	Objavljeno
Verzija publikacije:	Objavljena publikacija
Leto izida:	2013
Št. strani:	str. 37-38, 76
Številčenje:	Letn. 17, št. 1
PID:	20.500.12556/DiRROS-9030
UDK:	616.3-006
ISSN pri članku:	1408-1741
URN:	URN:NBN:SI:doc-MMKGNA7W
COBISS.SI-ID:	1554811
Avtorske pravice:	by Authors
Datum objave v DiRROS:	31.08.2018
Število ogledov:	3313
Število prenosov:	807
Metapodatki:
:	OBLAK, Irena, 2013, Sledenje bolnikov z rakom debelega črevesa in danke po radikalnem zdravljenju. V : Šola tumorjev prebavil, Ljubljana, 30. 11. 2012 [na spletu]. Objavljeni znanstveni prispevek na konferenci. 2013. p. 37–38, 76. [Dostopano 20 april 2025]. Pridobljeno s: https://dirros.openscience.si/IzpisGradiva.php?lang=slv&id=9030 Kopiraj citat

Objavi na:

Iščem podobna dela... Prosim, počakajte...

Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Naslov:	Šola tumorjev prebavil, Ljubljana, 30. 11. 2012
Založnik:	Onkološki inštitut
COBISS.SI-ID:	1553275

Licenca:	CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna

Povezava:	http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:	To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:	31.08.2018

Jezik:	Angleški jezik
Naslov:	Follow-up of colorectal cancer patients after radical treatment
Povzetek:	After completed treatment, either surgical or combined treatment of colorectal carcinoma, it is necessary to follow up patients regularly and in accordance with the recommended protocol. The purpose of such follow-up is to detect the disease or its recurrence as early as possible, including pre-cancerous lesions or potential metachronous (newly developed) tumours which can be treated successfully at an early stage. Follow-up is important also for the treatment of late complications, it enables psychological support to the patients, and finally, we can also track and assess our own performance. It is known that colorectal cancer recurs in 30 do 50% of patients. As many as 70% of recurrences are detected within the first two years, 80% in the first three years, and 90% or more disease recurrences are found within five years after surgery of the primary tumour. It has been shown that regular follow-up of patients after their treatment improves the outcome of their disease and reduces mortality in patients by 9% to 13%. We must adapt it to each patient separately, taking into account both his age and general condition, stage of the disease, concurrent diseases, and further treatment possibilities in the event of a recurrence.

niGradiv

Nazaj